Technical Analysis for CRY - CryoLife, Inc.

Grade Last Price % Change Price Change
D 22.65 0.49% 0.11
CRY closed up 0.49 percent on Thursday, April 15, 2021, on 41 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Apr 28
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat
Historical CRY trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Fell Below 20 DMA Bearish 0.49%
Shooting Star Candlestick Bearish 0.49%
Lizard Bearish Bearish Day Trade Setup 0.49%
180 Bearish Setup Bearish Swing Setup 0.49%
Bollinger Band Squeeze Range Contraction 0.49%
Doji - Bearish? Reversal 0.49%
Older End-of-Day Signals for CRY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 17 hours ago
Up 1% about 20 hours ago
10 DMA Support about 21 hours ago
Bearish 180 Entry about 21 hours ago
Lizard Bearish Entry about 21 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CryoLife, Inc. Description

CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications. It distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using CryoLife's proprietary SynerGraft technology; and vascular tissues comprising CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company also distributes surgical sealants and hemostats, including BioGlue Surgical Adhesive, an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels, as well as in repair of cardiac, vascular, pulmonary, and additional soft tissues. In addition, its surgical sealants and hemostats comprise BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; PerClot, an absorbable powdered hemostat agent used in surgery; and revascularization technologies, which include transmyocardial revascularization system for treating patients with stable angina that is not responsive to conventional therapy. CryoLife, through its subsidiary Cardiogenesis Corporation, specializes in the treatment of coronary artery disease for severe angina using a laser console system and single use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization. The company, through its subsidiary, Hemosphere, Inc., markets HeRO Graft, a solution for end-stage renal disease in certain hemodialysis patients. CryoLife distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Laser Surgery Dialysis Sealant Artery Hemodialysis Renal Disease Bypass Transplantation Circulatory System End Stage Renal Disease Stage Renal Disease Vein Artery Disease Vascular Surgery Angina Cardiovascular System Coronary Artery Disease Heart Valve Heart Valves Revascularization Treatment Of Coronary Artery Disease Yoli

Is CRY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.6
52 Week Low 16.13
Average Volume 146,078
200-Day Moving Average 21.29
50-Day Moving Average 24.04
20-Day Moving Average 22.60
10-Day Moving Average 22.58
Average True Range 0.70
ADX 22.86
+DI 16.90
-DI 21.63
Chandelier Exit (Long, 3 ATRs ) 22.39
Chandelier Exit (Short, 3 ATRs ) 23.84
Upper Bollinger Band 23.21
Lower Bollinger Band 21.98
Percent B (%b) 0.54
BandWidth 5.42
MACD Line -0.39
MACD Signal Line -0.48
MACD Histogram 0.096
Fundamentals Value
Market Cap 880.12 Million
Num Shares 38.9 Million
EPS 0.04
Price-to-Earnings (P/E) Ratio 514.77
Price-to-Sales 3.06
Price-to-Book 2.47
PEG Ratio 345.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.15
Resistance 3 (R3) 23.14 22.96 23.06
Resistance 2 (R2) 22.96 22.84 22.97 23.03
Resistance 1 (R1) 22.81 22.76 22.72 22.82 23.01
Pivot Point 22.63 22.63 22.59 22.64 22.63
Support 1 (S1) 22.48 22.51 22.39 22.49 22.29
Support 2 (S2) 22.30 22.43 22.31 22.27
Support 3 (S3) 22.15 22.30 22.24
Support 4 (S4) 22.16